Predicting biomarkers in intact older adults and those with amnestic Mild Cognitive Impairment, and mild Alzheimer's Disease using the Repeatable Battery for the Assessment of Neuropsychological Status.
Kayla R SuhrieDustin B HammersSariah M PorterAva M DixonJace B KingJeffrey S AndersonKevin DuffJohn M HoffmanPublished in: Journal of clinical and experimental neuropsychology (2022)
The RBANS - DMI in particular - is sensitive to AD pathology. As such, it could be used as a predictive tool, particularly in clinical drug trials to enrich samples prior to less accessible AD biomarker investigation.